TransMedics Group, Inc. (TMDX) saw its stock rise by 3.34% to close at $78.58 on November 25, 2024, up from the previous close of $76.04. The stock opened at $77.99 and reached a high of $78.99 during the trading session, with a volume of 1,486,043 shares, which is 94.91% of its average daily volume. The upward movement was primarily driven by positive sentiment in the artificial organs market, which is projected to grow significantly, reaching a value of USD 86.46 billion by 2031. This optimistic outlook has likely bolstered investor confidence in TransMedics, a key player in the industry. Additionally, the disclosure of a new stake by Thrivent Financial for Lutherans, which acquired 26,196 shares valued at approximately $4,113,000, further fueled the stock's rise.